Adept Therapeutics Inc

Adept Therapeutics Inc.(AdeptTx) is an innovative start-up biotech company located at Beverly in Great Boston area, MA, with passion and commitment to discover and develop potentially life-changing medicines for people with unmet medical needs. Focusing on T cells, Natural Killer cells and immune-suppressive myeloid cells, we leverage multiple advanced antibody technologies to discover fully human or humanized antibody therapeutics to enhance anti-tumor immunity. We are establishing and optimizing two unique platforms including immune cell engager bispecific antibodies and multi-functional tri-specific antibodies, which change tumor microenvironment (TME) to boost immune responses against cancer cells through 1) recruiting and activating effector immune cells and 2) modulating immune-suppressive TME to support tumor killing effector cell function. Our expertise in GPCR antibody discovery and development enable us to reach for the “high-hanging fruits”, the most challenging targets for antibody therapeutics discovery. Our broad product portfolio focuses on both hematological malignancies, such as cutaneous lymphoma, and solid tumors including triple negative breast cancer, ovarian, colon, kidney, renal, prostate, and pancreatic cancers etc.